Bojan Miletic

Prof. Dr. Bojan Miletic

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
WBWerner Benzer
Werner Benzer
BRBernhard Rauch
Bernhard Rauch
JSJean-Paul Schmid
Jean-Paul Schmid
AZAnn Dorthe Zwisler
Ann Dorthe Zwisler
PDPaul Dendale
Paul Dendale
HMHannah McGee
Hannah McGee

6 July 2011 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
GLGordana Laškarin
Gordana Laškarin
VPV. Persic
V. Persic
ARAlen Ružić
Alen Ružić
BMBojan Miletic
Bojan Miletic
MRMarijana Rakić
Marijana Rakić
DRD. Rukavina
D. Rukavina

8 March 2006 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
MMMiro Morovic
Miro Morovic
IPIvica Poljak
Ivica Poljak
BMBojan Miletic
Bojan Miletic
BTBiserka Troselj-Vukic
Biserka Troselj-Vukic
ISIrena Seili-Bekafigo
Irena Seili-Bekafigo
IMIrena Milotic
Irena Milotic
Miro Morovic, Ivica Poljak, Bojan Miletic, Biserka Troselj-Vukic, Irene Seili-Bekafigo, Irena Milotic; Late Symptomatic Plasmodium malariae Relapse in the Terr

20 December 2013 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
MBM. Boban
M. Boban
VPV. Persic
V. Persic
ŽJŽeljko Jovanović
Željko Jovanović
ABA. Brozina
A. Brozina
BMBojan Miletic
Bojan Miletic
LBL. Boban
L. Boban
Obesity is a well-known risk factor in the cardiovascular disease continuum. However, its clinical effects are multimodal, perplexed and non-unanimously understood. Our aim was to assess the prevalence and effects of obesity on the cardiometabolic risk factors and systolic function of left ventricle ejection fraction (LVEF) in patients scheduled for cardiovascular rehabilitation. A cohort of 302 consecutive patients recently treated for ischaemic or valvular heart disease was matched according to the existence of obesity, defined with body mass index (BMI ≥ 30 kg/m(2) ; n = 90 vs. 212), and the advanced grade of obesity (BMI ≥ 35 kg/m(2) ; n = 19 vs. 283). Nutritional risk screening was performed using the standardised NRS-2002 tool. The mean age of patients was 62.4 ± 11.2 (range 23-86) years; there were more men than women 244 (80.8%) : 58 (19.2%). Group of obese conveyed higher prevalence of ischaemic heart disease than non-obese (OR = 2.69; 95% CI: 1.01-7.20; p = 0.048); while the difference was insignificant for the advanced grade of obesity (n = 17; 89.5%) vs. controls (n = 233; 82.3%; p > 0.05). There was no significant difference in prevalence of other comorbidities (diabetes, glucose intolerance, hypercholesterolaemia, chronic renal and chronic obstructive pulmonary disease) between studied groups (p > 0.05). Utilisation of lipid-lowering drugs was of similar range between the studied groups (p > 0.05), respectively. LVEF (%) was 50.5 ± 8.2 vs. 50.7 ± 7.7 (p > 0.05) and 50.6 ± 7.8 vs. 49.6 ± 10.9 (p > 0.05; Rho = 0.001; p > 0.05), respectively. In studied set of patients, BMI positively correlated with left ventricle dimension and thickness. No significant connection of obesity was found with the prevalence of chronic comorbidities, increased nutritional risk, laboratory diagnostics or systolic function of left ventricle. Existence of obesity paradox in clinical practice was in part reaffirmed with our study.

3 October 2011 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
VPV. Persic
V. Persic
ARAlen Ružić
Alen Ružić
BMBojan Miletic
Bojan Miletic
DSD. Travica Samsa
D. Travica Samsa
MRMarijana Rakić
Marijana Rakić
GLGordana Laškarin
Gordana Laškarin
We aimed to analyse granulysin (GNLY)‐mediated cytotoxicity in the peripheral blood of patients with non‐ST‐segment elevation myocardial infarction (NSTEMI) treated with anti‐ischaemic drug therapy. Thirty‐nine NSTEMI patients with a median age of 70 years and 28 age‐matched healthy subjects were enrolled in this study. On day 7 after MI, the number of GNLY+ lymphocytes in the peripheral blood increased approximately six‐fold of that in the healthy subjects, measured by flow cytometry. On day 14, the number of GNLY+ cells significantly decreased in T, NKT, and both CD56+dim and CD56+bright NK subsets. GNLY+ CD3+ and GNLY+ CD56+ cells infiltrated central zone of myocardial infarction (MI). In persons who died in the first week after MI, GNLY+ cells were found within accumulation of apoptotic leucocytes and reached the apoptotic cardiomyocytes in border MI zones probably due to the influence of interleukin‐15 in peri‐necrotic cardiomyocytes, as it is was shown by immunohistology. By day 28, the percentage of GNLY+ lymphocytes in peripheral blood returned to the levels similar to that of the healthy subjects. Anti‐GNLY mAb decreased apoptosis of K562 targets using peripheral blood NK cells from days 7 and 28 after MI, while in assays using cells from days 1 and 21, both anti‐GNLY and anti‐perforin mAbs were required to significantly decrease apoptosis. Using NK cells from day 14, K562 apoptosis was nearly absent. In conclusion, it seems that GNLY+ lymphocytes, probably attracted by IL‐15, not only participate partially in myocardial cell apoptosis, but also hasten resolution of cardiac leucocyte infiltration in patients with NSTEMI.

9 July 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
BMBojan Miletic
Bojan Miletic
YSYves Sutter
Yves Sutter
GSGordana Starčević-Klasan
Gordana Starčević-Klasan
UCUdo Courteney
Udo Courteney
Lejla JelovicaLejla Jelovica
Lejla Jelovica
SŠSilvije Šegulja
Silvije Šegulja
Introduction: Nutritional deficiency among the older adult is a widespread concern, significantly affecting their health. The prevalence of malnutrition increases with age, concurrent health conditions, and the level of care provided. Hospital stays can affect as 90% of the older adult. Malnutrition can hinder efforts to improve health and regain function in individuals undergoing rehabilitation. This study aims to assess the frequency of malnutrition among geriatric rehabilitation patients.Materials and methods: A retrospective quantitative analysis was conducted on 357 patients admitted to the geriatric unit at Lucerne Cantonal Hospital Wolhusen in Switzerland. The patients’ nutritional status was evaluated using the standardized Mini Nutritional Assessment Long Form questionnaire.Results: The initial analysis indicated a considerable prevalence of malnutrition among the geriatric population: 31.1% were identified as malnourished (MNA < 17), while an additional 35.8% were at risk of malnutrition (MNA 17–23.5), totaling 66.9% of patients. The Kruskal-Wallis ANOVA test revealed a statistically significant difference in MNA scores among different age groups (p = 0.035). Statistical analysis also suggested a slightly higher prevalence of malnutrition among female patients. The duration of rehabilitation varied from 20.07 ± 6.93 to 22.20 ± 7.50 days, with longer durations associated with lower MNA scores. A correlation analysis between MNA values and body mass index (BMI) showed a positive correlation coefficient (r = 0.56), indicating that lower MNA scores were associated with lower BMI and vice versa.Conclusion: Malnutrition is prevalent among individuals over 65 years old, highlighting the importance of regular and timely nutritional assessments for geriatric patients to mitigate the complications and enhance prognoses in both acute care and rehabilitation settings. Such assessments can also improve the efficacy of rehabilitation programs and potentially reduce the duration of rehabilitation, thus carrying significant economic implications.